Back to search
FDAFDA · Food and drugs·Recall number D-1703-2012

Famotidine Tablets USP, 20 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-3020-01

Published October 10, 2012 · Recall initiated: June 28, 2012

Summary

FDA records drug Class III recall D-1703-2012, published October 10, 2012 and initiated June 28, 2012. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 31,867 Bottles; Lot: Lot: 3018952, Exp 08/12. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Impurities/Degradation Products: Out of specification results for Related Compound during routine stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
Nationwide and PR
Lot
Lot: 3018952, Exp 08/12
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Famotidine Tablets USP, 20 mg, 100 count bottles, Rx Only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-3020-01 recalled?

Yes. FDA published recall D-1703-2012 on October 10, 2012. Reported hazard: Impurities/Degradation Products: Out of specification results for Related Compound during routine stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter